Table 2.
Patient baseline characteristics in the group with HL and high ratio of neutrophils (n = 134). APACHE, Acute Physiologic Assessment and Chronic Health Evaluation.
| Parameters | High level (n = 87) | Low level (n = 47) | P‐value |
|---|---|---|---|
| Age (years), mean ± SD | 62.1 ± 17.4 | 59.7 ± 12.8 | 0.248 |
| Male, n (%) | 40 (45.9) | 27 (57.4) | 0.131 |
| Neutrophils (%), mean ± SD | 85.2 ± 4.1 | 81.3 ± 2.6 | 0.043 |
| Leukocytes (×109), mean ± SD | 15.6 ± 2.2 | 16.0 ± 2.6 | 0.141 |
| TSLP levels (pg·mL−1), mean ± SD | 425.6 ± 52.4 | 305.6 ± 21.6 | 0.004 |
| C‐reactive protein (mg·L−1), mean ± SD | 8.3 ± 1.1 | 7.7 ± 1.4 | 0.052 |
| Procalcitonin, mean ± SD | 2.81 ± 0.47 | 2.03 ± 0.34 | 0.031 |
| Random blood glucose (mmol·L−1), mean ± SD | 9.4 ± 1.2 | 9.7 ± 1.7 | 0.067 |
| Organ dysfunction, n (%) | |||
| Acute respiratory syndrome | 53 (60.9) | 17 (36.1) | 0.012 |
| Renal failure | 40 (45.9) | 15 (31.9) | 0.057 |
| Heart failure | 10 (11.5) | 7 (14.9) | 0.128 |
| Multiple organ dysfunction, n (%) | 36 (41.3) | 9 (19.1) | 0.045 |
| Septic shock, n (%) | 22 (25.2) | 7 (14.8) | 0.072 |
| Heart rate, mean ± SD | 102.3 ± 16.7 | 98.7 ± 21.5 | 0.081 |
| Respiratory rate, mean ± SD | 25.7 ± 6.8 | 23.3 ± 5.9 | 0.140 |
| Blood pressure (mmHg), mean ± SD | |||
| Systolic | 121.8 ± 27.6 | 126.5 ± 31.6 | 0.081 |
| Diastolic | 77.1 ± 21.1 | 82.3 ± 17.8 | 0.096 |
| APACHE II score, mean ± SD | 25.1 ± 4.1 | 20.2 ± 3.7 | 0.017 |
| In‐hospital mortality, n (%) | 31 (35.6) | 6 (12.7) | 0.021 |
| Length of stay in ICU (days), mean ± SD | 9.7 ± 2.1 | 7.5 ± 1.0 | 0.015 |
| Comorbidity, n (%) | |||
| Chronic obstructive pulmonary disease | 46 (52.8) | 30 (53.1) | 0.380 |
| Diabetes | 23 (26.4) | 10 (21.2) | 0.313 |
| Coronary artery disease | 16 (18.3) | 7 (14.9) | 0.265 |
| Cancer | 5 (5.7) | 3 (6.3) | 0.246 |